RxDoctor Payments Data

Christopher Macomber, MD

Surgery · Minneapolis, MNNPI 1063648855

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $44,920 of the $55,307 with a category attached, or 81.2%. Davol Inc. accounts for 71.7% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $32,522, more than ten times the $1,215 reported in 2019. Among surgery clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$55,307in general payments, 2019–2025

Across 76 payments — averaging $727.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Davol Inc.$40K
  • Medtronic$10K
  • Intuitive Surgical$2K
  • BD$1K
  • Medical Device Business Services, Inc.$1K
  • Steris Corporation$342
  • plus $140 from 2 others

What the payments were for

  • Consulting fees$1,0502%
  • Speaking & faculty fees$44,92081%
  • Travel & lodging$6,47112%
  • Food & beverage$2,6535%
  • Education$1970%
  • Gifts$160%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,307 in reported general payments places this provider in the 95th percentile of 498 surgery providers in Minnesota.

See all surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$87,529
Medicare patients
117
Services billed
272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl12$60

Paid to pharmacies, not to this prescriber.

Other surgery in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →